GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ. by Ziyue Liu (381532)

“…<p>GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ.</p>…”

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression. by Lei Li (29537)

“…<p>(A) NEAT1 expression following siRNA transfection in BEAS-2B cells; (B-D) The expression of NEAT1, miR-204-5p, and Six1 after decreasing NEAT1 expression. * p <0.05, *** p < 0.001, and **** p <0.0001.…”

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

“…<p><b>(A)</b> Manhattan plot of minJSW decrease at 24 months. The Manhattan plots show the -log10(P) values of all ~ 1,5 million SNPs against their position. …”

Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

Disruption of putative host factor LGMN decreases SARS-CoV-2 viral entry. by Ravi K. Dinesh (21736629)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Additional file 5 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Assessment of conditions associated with decrease in systemic vascular resistance one month prior to NAION onset and in matched controls. by Jasmin Gabbay (20323916)

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. by Mieke L. M. Bentvelzen (21594442)

“…<p>Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA.…”

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

Degeneration Saline group presented with significant decreased final weight in relation to other groups. by Flavia Gomes Velasque Gama (21175112)

Subjects:

<i>B. bassiana</i> decreased longevity and impaired climbing. by Deepanshu N. D. Singh (20721878)

SBP3 KD decreases the surface localization of VESA-1. by Atefeh Fathi (7370876)

Disrupting the PI3K complex decreases the antiviral activity of autophagy. by Ruonan Zhang (358761)

PMC exhibits less sensitivity to decreasing signal-to-noise ratio (SNR) by Owen Puls (22340344)

Wnt signaling decreases the recruitment of RAB8a to basal bodies. by Cheng Yuan (160315)

LncRNA <i>C5orf64</i> polymorphisms (rs12518552 and rs2950218) decreases pulmonary tuberculosis susceptibility by Shilin Xu (1884217)